New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Test can predict how people with leukaemia will respond to chemotherapy

Test can predict how people with leukaemia will respond to chemotherapy

by BloodwiseCredit: CC0 Public DomainThe first test to quickly and accurately predict how people will respond to standard treatment for the most common type of leukaemia has been developed at Cardiff
Oncology April 18,2024
Test can predict how people with leukaemia will respond to chemotherapy

Test can predict how people with leukaemia will respond to chemotherapy

by BloodwiseCredit: CC0 Public DomainThe first test to quickly and accurately predict how people will respond to standard treatment for the most common type of leukaemia has been developed at Cardiff
Oncology April 18,2024
Latest results from clinical trial show patients with advanced HER2-positive breast cancer live longer on pyrotinib

Latest results from clinical trial show patients with advanced HER2-positive breast cancer live longer on pyrotinib

by Associação Advanced Breast Cancer Global AllianceCredit: Unsplash/CC0 Public DomainPatients with HER2-positive breast cancer that has started to spread to other parts of the body survive for longer
Oncology April 18,2024
Latest results from clinical trial show patients with advanced HER2-positive breast cancer live longer on pyrotinib

Latest results from clinical trial show patients with advanced HER2-positive breast cancer live longer on pyrotinib

by Associação Advanced Breast Cancer Global AllianceCredit: Unsplash/CC0 Public DomainPatients with HER2-positive breast cancer that has started to spread to other parts of the body survive for longer
Oncology April 18,2024
Enhanced anticancer compound may allow precise activation and tracking of treatment

Enhanced anticancer compound may allow precise activation and tracking of treatment

by The Wistar InstituteCredit: The Wistar InstituteResearchers at The Wistar Institute and the University of South Florida have advanced a novel compound that specifically targets the endoplasmic
Oncology April 18,2024
Enhanced anticancer compound may allow precise activation and tracking of treatment

Enhanced anticancer compound may allow precise activation and tracking of treatment

by The Wistar InstituteCredit: The Wistar InstituteResearchers at The Wistar Institute and the University of South Florida have advanced a novel compound that specifically targets the endoplasmic
Oncology April 18,2024
Brain boost: Can a coach help elders at risk for Alzheimer's?

Brain boost: Can a coach help elders at risk for Alzheimer's?

by University of California, San FranciscoCredit: Unsplash/CC0 Public DomainAs more medications move towards federal approval for Alzheimer's disease, a new study led by researchers at UC San
Oncology April 18,2024
Brain boost: Can a coach help elders at risk for Alzheimer's?

Brain boost: Can a coach help elders at risk for Alzheimer's?

by University of California, San FranciscoCredit: Unsplash/CC0 Public DomainAs more medications move towards federal approval for Alzheimer's disease, a new study led by researchers at UC San
Oncology April 18,2024
Boosting the cancer-destroying ability of killer T-cells

Boosting the cancer-destroying ability of killer T-cells

by Julia Short,Cardiff UniversityCredit: CC0 Public DomainMore types of cancer could potentially be destroyed by patients' own immune cells, thanks to new research by Cardiff University.The
Oncology April 18,2024
Boosting the cancer-destroying ability of killer T-cells

Boosting the cancer-destroying ability of killer T-cells

by Julia Short,Cardiff UniversityCredit: CC0 Public DomainMore types of cancer could potentially be destroyed by patients' own immune cells, thanks to new research by Cardiff University.The
Oncology April 18,2024
Study sheds light on the function of a long-mysterious PCSK9 mutation

Study sheds light on the function of a long-mysterious PCSK9 mutation

by American Society for Biochemistry and Molecular BiologyCredit: CC0 Public DomainHigh levels of low-density lipoproteins, parcels of lipids and protein that carry cholesterol, are a leading ris
Oncology April 18,2024
Study sheds light on the function of a long-mysterious PCSK9 mutation

Study sheds light on the function of a long-mysterious PCSK9 mutation

by American Society for Biochemistry and Molecular BiologyCredit: CC0 Public DomainHigh levels of low-density lipoproteins, parcels of lipids and protein that carry cholesterol, are a leading ris
Oncology April 18,2024
Book examines the circuitous history behind the investigation of cancer as a contagious illness

Book examines the circuitous history behind the investigation of cancer as a contagious illness

by Peter Dizikes,Massachusetts Institute of TechnologyRobin Scheffler and his new book, “A Contagious Cause: The American Hunt for Cancer Viruses and the Rise of Molecular Medicine.” Credit: Jon
Oncology April 18,2024
Book examines the circuitous history behind the investigation of cancer as a contagious illness

Book examines the circuitous history behind the investigation of cancer as a contagious illness

by Peter Dizikes,Massachusetts Institute of TechnologyRobin Scheffler and his new book, “A Contagious Cause: The American Hunt for Cancer Viruses and the Rise of Molecular Medicine.” Credit: Jon
Oncology April 18,2024
Turbocharging the body's natural killer cells to defeat cancer

Turbocharging the body's natural killer cells to defeat cancer

by Monash UniversityDr. Jai Rautela and Professor Nicholas Huntington. Credit: Monash UniversityNatural Killer (NK) cells have long been the soldiers of the immune system that prevents the growth
Oncology April 18,2024
Turbocharging the body's natural killer cells to defeat cancer

Turbocharging the body's natural killer cells to defeat cancer

by Monash UniversityDr. Jai Rautela and Professor Nicholas Huntington. Credit: Monash UniversityNatural Killer (NK) cells have long been the soldiers of the immune system that prevents the growth
Oncology April 18,2024
Technique targets cancer cells and leaves healthy ones alone

Technique targets cancer cells and leaves healthy ones alone

by Hebrew University of JerusalemTRPV2 protein in action. Credit: Hebrew University of JerusalemIt is a feeling that many who receive a cancer diagnosis can identify with: heartbreak and fear, fo
Oncology April 18,2024
Technique targets cancer cells and leaves healthy ones alone

Technique targets cancer cells and leaves healthy ones alone

by Hebrew University of JerusalemTRPV2 protein in action. Credit: Hebrew University of JerusalemIt is a feeling that many who receive a cancer diagnosis can identify with: heartbreak and fear, fo
Oncology April 18,2024
Boosting immune system in chronic myeloid leukemia may lead to discontinuation of blood cancer drugs

Boosting immune system in chronic myeloid leukemia may lead to discontinuation of blood cancer drugs

by University of HelsinkiSchematics showing the overview of data sets, analysis, and validation and extensions. Picture created with biorender.com. Credit:Leukemia(2023). DOI: 10.1038
Oncology April 18,2024
Boosting immune system in chronic myeloid leukemia may lead to discontinuation of blood cancer drugs

Boosting immune system in chronic myeloid leukemia may lead to discontinuation of blood cancer drugs

by University of HelsinkiSchematics showing the overview of data sets, analysis, and validation and extensions. Picture created with biorender.com. Credit:Leukemia(2023). DOI: 10.1038
Oncology April 18,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com